BPA for xtandi, xospata.
Ended Awarded Last action
- Contract number
- 36E79722A0001
- Awardee
-
Astellas Pharma US, Inc. UEI NKGHPQKJQWC1
- Awarding agency
-
National Acquisition Center
Headquarters, Department of Veterans Affairs
- Task orders
- 0
Award facts
- Opportunity
-
- VA797P12Q0002 Solicitation number
- Last date to order 100% complete
- IDV ceiling
- $296,500.00
- Award type
- Single award
- Who can order
- Only the awarding agency
- Contracting staff
- NAICS code
- 325412 Pharmaceutical Preparation Manufacturing
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition · 1 offer Multiple Award, Fair Opportunity
- Pricing
- Firm Fixed Price
Award details come from SAM.gov/FPDS.
About this IDV
This Blanket Purchase Agreement, awarded by the Veterans Health Administration's National Acquisition Center on October 7, 2021, establishes a single-award contract with Astellas Pharma US, Inc. for the supply of specialty oncology pharmaceuticals, specifically XTANDI (enzalutamide) and XOSPATA (gilteritinib). The contract, valued at $296,500.00 with a ceiling completion date of October 6, 2026, is established against the Pharmaceuticals and Drugs Federal Supply Schedule (GSA Schedule 61-IB). No set-asides were used in this award. Astellas Pharma US, Inc., a foreign-owned pharmaceutical manufacturer with a Unique Entity Identifier of NKGHPQKJQWC1, was selected as the prime contractor based on its established relationships with the Veterans Health Administration and demonstrated capacity to supply critical biologic and specialty pharmaceutical products to federal healthcare facilities.
The contract supports the Veterans Health Administration's procurement needs for two distinct oncology medications: XTANDI, indicated for the treatment of prostate cancer in advanced stages, and XOSPATA, used in hematologic malignancies. These pharmaceuticals will be distributed to Veterans Health Administration medical facilities under delivery orders placed against this BPA. The contract's structure allows for flexible purchasing throughout the performance period, with the $296,500.00 ceiling establishing the maximum financial obligation for all orders issued under this agreement. This BPA represents the government's commitment to ensuring consistent access to these specialized life-sustaining medications for eligible veteran patients while leveraging existing GSA Schedule pricing to optimize procurement efficiency and cost management.
Transactions
| Action | Obligated | Date |
|---|---|---|
| Supplemental Agreement for work within scope | $0 | |
| Supplemental Agreement for work within scope | $0 | |
| Supplemental Agreement for work within scope | $0 | |
| Exercise an Option | $0 | |
| Supplemental Agreement for work within scope | $0 | |
| Supplemental Agreement for work within scope | $0 | |
| Supplemental Agreement for work within scope | $0 | |
| Supplemental Agreement for work within scope | $0 | |
| Supplemental Agreement for work within scope | $0 | |
| Supplemental Agreement for work within scope | $0 | |
| Supplemental Agreement for work within scope | $0 | |
| Exercise an Option | $0 | |
| Supplemental Agreement for work within scope | $0 | |
| Supplemental Agreement for work within scope | $0 | |
| Exercise an Option | $0 | |
| Supplemental Agreement for work within scope | $0 | |
| Supplemental Agreement for work within scope | $0 | |
| Exercise an Option | $0 | |
| Supplemental Agreement for work within scope | $0 | |
| Supplemental Agreement for work within scope | $0 | |
| Original award | $0 |
Show all 21
Quick answers
Who was awarded contract 36E79722A0001?
36E79722A0001 was awarded to Astellas Pharma US, Inc. by National Acquisition Center (Headquarters) on October 7, 2021.
How much is contract 36E79722A0001 worth?
36E79722A0001's own ceiling is $296,500.
Who can order from contract 36E79722A0001?
36E79722A0001 is a single award blanket purchase agreement. Only the awarding agency can place orders on it.
Is contract 36E79722A0001 under another contract?
Yes. 36E79722A0001 is a blanket purchase agreement under 36F79721D0260, a federal supply schedule, on Pharmaceuticals and Drugs (FSS-61-IB).
Was contract 36E79722A0001 competed?
The extent of competition for 36E79722A0001 was full and open competition. The government received 1 offer.
On GovTribe
See this IDV's full record
- Every order and transaction
- The awardee's other awards and teaming partners
- Similar IDVs and recompete opportunities
- Ask GovTribe AI about this IDV